| pubmed-article:16528530 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16528530 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:16528530 | lifeskim:mentions | umls-concept:C0009375 | lld:lifeskim |
| pubmed-article:16528530 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:16528530 | lifeskim:mentions | umls-concept:C0042006 | lld:lifeskim |
| pubmed-article:16528530 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
| pubmed-article:16528530 | lifeskim:mentions | umls-concept:C1709059 | lld:lifeskim |
| pubmed-article:16528530 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:16528530 | pubmed:dateCreated | 2006-8-9 | lld:pubmed |
| pubmed-article:16528530 | pubmed:abstractText | The purpose of this investigation was to evaluate the effectiveness of oral 5-(phenylthio)acyclouridine (PTAU) in reducing 5-fluorouracil (FUra) host-toxicity and enhancing its chemotherapeutic efficacy against human colon tumors. PTAU is a potent and specific inhibitor of uridine phosphorylase (UrdPase, EC 2.4.2.3), the enzyme responsible for uridine catabolism. | lld:pubmed |
| pubmed-article:16528530 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16528530 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16528530 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16528530 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16528530 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16528530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16528530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16528530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16528530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16528530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16528530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16528530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16528530 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16528530 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16528530 | pubmed:issn | 0344-5704 | lld:pubmed |
| pubmed-article:16528530 | pubmed:author | pubmed-author:SchinaziRaymo... | lld:pubmed |
| pubmed-article:16528530 | pubmed:author | pubmed-author:el... | lld:pubmed |
| pubmed-article:16528530 | pubmed:author | pubmed-author:ShiJunxingJ | lld:pubmed |
| pubmed-article:16528530 | pubmed:author | pubmed-author:Al... | lld:pubmed |
| pubmed-article:16528530 | pubmed:author | pubmed-author:NaguibFardos... | lld:pubmed |
| pubmed-article:16528530 | pubmed:author | pubmed-author:RaisReemR | lld:pubmed |
| pubmed-article:16528530 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16528530 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:16528530 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16528530 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16528530 | pubmed:pagination | 692-8 | lld:pubmed |
| pubmed-article:16528530 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:meshHeading | pubmed-meshheading:16528530... | lld:pubmed |
| pubmed-article:16528530 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16528530 | pubmed:articleTitle | Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor. | lld:pubmed |
| pubmed-article:16528530 | pubmed:affiliation | Department of Pharmacology and Toxicology, Comprehensive Cancer Center, Center for Aids Research, University of Alabama at Birmingham, Birmingham, AL 35294, USA. | lld:pubmed |
| pubmed-article:16528530 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16528530 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:16528530 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16528530 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16528530 | lld:pubmed |
